jiang, ying - Search Results

Year	Number of Results
2001	1
2002	13
2003	14
2004	7
2005	19
2006	22
2007	28
2008	31
2009	35
2010	59
2011	55
2012	72
2013	101
2014	89
2015	109
2016	120
2017	111
2018	144
2019	174
2020	188
2021	173
2022	247
2023	230
2024	99

1

Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment.

Jiang Y, Cheng Y, Ma S, Li T, Chen Z, Zuo X, Zhang X. Jiang Y, et al. J Autoimmun. 2022 Oct;132:102887. doi: 10.1016/j.jaut.2022.102887. Epub 2022 Aug 25. J Autoimmun. 2022. PMID: 36030136 Review.

2

Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma.

Jiang Y, Sun A, Zhao Y, Ying W, Sun H, Yang X, Xing B, Sun W, Ren L, Hu B, Li C, Zhang L, Qin G, Zhang M, Chen N, Zhang M, Huang Y, Zhou J, Zhao Y, Liu M, Zhu X, Qiu Y, Sun Y, Huang C, Yan M, Wang M, Liu W, Tian F, Xu H, Zhou J, Wu Z, Shi T, Zhu W, Qin J, Xie L, Fan J, Qian X, He F; Chinese Human Proteome Project (CNHPP) Consortium. Jiang Y, et al. Nature. 2019 Mar;567(7747):257-261. doi: 10.1038/s41586-019-0987-8. Epub 2019 Feb 27. Nature. 2019. PMID: 30814741

3

Caveolin-1 controls mitochondrial damage and ROS production by regulating fission - fusion dynamics and mitophagy.

Jiang Y, Krantz S, Qin X, Li S, Gunasekara H, Kim YM, Zimnicka A, Bae M, Ma K, Toth PT, Hu Y, Shajahan-Haq AN, Patel HH, Gentile S, Bonini MG, Rehman J, Liu Y, Minshall RD. Jiang Y, et al. Redox Biol. 2022 Jun;52:102304. doi: 10.1016/j.redox.2022.102304. Epub 2022 Apr 6. Redox Biol. 2022. PMID: 35413643 Free PMC article.

4

Targeting p53-MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials.

Zhu H, Gao H, Ji Y, Zhou Q, Du Z, Tian L, Jiang Y, Yao K, Zhou Z. Zhu H, et al. Among authors: jiang y. J Hematol Oncol. 2022 Jul 13;15(1):91. doi: 10.1186/s13045-022-01314-3. J Hematol Oncol. 2022. PMID: 35831864 Free PMC article. Review.

5

Loss of the receptors ER, PR and HER2 promotes USP15-dependent stabilization of PARP1 in triple-negative breast cancer.

Sun X, Tang H, Chen Y, Chen Z, Hu Z, Cui Z, Tao Y, Yuan J, Fu Y, Zhuang Z, He Q, Li Q, Xu X, Wan X, Jiang Y, Mao Z. Sun X, et al. Among authors: jiang y. Nat Cancer. 2023 May;4(5):716-733. doi: 10.1038/s43018-023-00535-w. Epub 2023 Apr 3. Nat Cancer. 2023. PMID: 37012401

6

Farrerol directly activates the deubiqutinase UCHL3 to promote DNA repair and reprogramming when mediated by somatic cell nuclear transfer.

Zhang W, Wang M, Song Z, Fu Q, Chen J, Zhang W, Gao S, Sun X, Yang G, Zhang Q, Yang J, Tang H, Wang H, Kou X, Wang H, Mao Z, Xu X, Gao S, Jiang Y. Zhang W, et al. Among authors: jiang y. Nat Commun. 2023 Apr 3;14(1):1838. doi: 10.1038/s41467-023-37576-9. Nat Commun. 2023. PMID: 37012254 Free PMC article.

7

Effectiveness of mindfulness-based interventions on psychological well-being, burnout and post-traumatic stress disorder among nurses: A systematic review and meta-analysis.

Ramachandran HJ, Bin Mahmud MS, Rajendran P, Jiang Y, Cheng L, Wang W. Ramachandran HJ, et al. Among authors: jiang y. J Clin Nurs. 2023 Jun;32(11-12):2323-2338. doi: 10.1111/jocn.16265. Epub 2022 Feb 20. J Clin Nurs. 2023. PMID: 35187740 Review.

8

CD200⁺ cytotoxic T lymphocytes in the tumor microenvironment are crucial for efficacious anti-PD-1/PD-L1 therapy.

Wang X, Zha H, Wu W, Yuan T, Xie S, Jin Z, Long H, Yang F, Wang Z, Zhang A, Gao J, Jiang Y, Wang L, Hu C, Wan YY, Li QJ, Symonds ALJ, Jia Q, Zhu B. Wang X, et al. Among authors: jiang y. Sci Transl Med. 2023 Jan 18;15(679):eabn5029. doi: 10.1126/scitranslmed.abn5029. Epub 2023 Jan 18. Sci Transl Med. 2023. PMID: 36652534

9

Hypoxia-Induced Scleral HIF-2α Upregulation Contributes to Rises in MMP-2 Expression and Myopia Development in Mice.

Wu W, Su Y, Hu C, Tao H, Jiang Y, Zhu G, Zhu J, Zhai Y, Qu J, Zhou X, Zhao F. Wu W, et al. Among authors: jiang y. Invest Ophthalmol Vis Sci. 2022 Jul 8;63(8):2. doi: 10.1167/iovs.63.8.2. Invest Ophthalmol Vis Sci. 2022. PMID: 35802383 Free PMC article.

10

Lysosomal dysfunction in Down syndrome and Alzheimer mouse models is caused by v-ATPase inhibition by Tyr⁶⁸²-phosphorylated APP βCTF.

Im E, Jiang Y, Stavrides PH, Darji S, Erdjument-Bromage H, Neubert TA, Choi JY, Wegiel J, Lee JH, Nixon RA. Im E, et al. Among authors: jiang y. Sci Adv. 2023 Jul 28;9(30):eadg1925. doi: 10.1126/sciadv.adg1925. Epub 2023 Jul 26. Sci Adv. 2023. PMID: 37494443 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

1,901 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

1,901 results

Results by year